<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="308212">
  <stage>Registered</stage>
  <submitdate>13/07/2009</submitdate>
  <approvaldate>15/07/2009</approvaldate>
  <actrnumber>ACTRN12609000587202</actrnumber>
  <trial_identification>
    <studytitle>Maternal Sleep Health and Foetal Outcomes</studytitle>
    <scientifictitle>The relationship between maternal sleep health and foetal growth restriction and cardiotocography (CTG) in pregnant women at risk of sleep-disordered breathing versus healthy pregnant women.</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Obstructive Sleep Apnoea</healthcondition>
    <healthcondition>Maternal sleep health</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Sleep apnoea</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Fetal medicine and complications of pregnancy</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Foetal growth will be observed via ultrasound at 32 and 36 weeks gestation, and at birth.
Sleep and foetal heart rate will be monitored with polysomnography and cardiotocography at 38 weeks gestation, for one 8 hour overnight session.</interventions>
    <comparator>No treatment given</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Infant birth weight - A &gt;1/3 fall in birth weight percentile from expected will be considered as slowed late foetal growth.</outcome>
      <timepoint>32 weeks gestation, 36 weeks gestation, delivery.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>abnormal cardiotocography</outcome>
      <timepoint>38 weeks gestation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>blood sample and cord blood for detection of elevated levels of cytokines and markers of oxidative stress.</outcome>
      <timepoint>28 weeks gestation, delivery.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>between 20-24 weeks gestation
Risk factors for sleep disordered breathing, including pre-pregnant obesity (Body Mass Index (BMI) greater than 30kg/m2) and snoring (cases); healthy controls with no history of snoring.</inclusivecriteria>
    <inclusiveminage>0</inclusiveminage>
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Multiple pregnancy, current pregnancy complicated by pre-eclampsia, previously diagnosed and treated Obstructive Sleep Apnoea (OSA) or other sleep disorder, e.g. narcolepsy, periodic leg movements in sleep (PLMS).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Screening</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Defined population</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/08/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <postcode>3084</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Charities/Societies/Foundations</primarysponsortype>
    <primarysponsorname>Institute for Breathing and Sleep</primarysponsorname>
    <primarysponsoraddress>Bowen Centre
Austin Health
Studley Road
Heidelberg VIC, 3084</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Institute for Breathing and Sleep</fundingname>
      <fundingaddress>Bowen Centre
Austin Health
Studley Road
Heidelberg , VIC, 3084</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Mercy Hospital for Women</sponsorname>
      <sponsoraddress>Studley Road
Heidelberg, VIC, 3084</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The study will investigate the association between sleep-disordered breathing during pregnancy and foetal growth and well-being.  It is hypothesised that Obstructive Sleep Apnoea is detrimental to foetal health (acute foetal compromise as evidenced by abnormal cardiotocography (foetal heart rate monitoring) during sleep and impaired foetal growth in late pregnancy).</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Austin Health</ethicname>
      <ethicaddress>Studley Road
Heidelberg, VIC, 3084</ethicaddress>
      <ethicapprovaldate>7/05/2009</ethicapprovaldate>
      <hrec>03514</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Mercy Hospital for Women</ethicname>
      <ethicaddress>Studley Road
Heidelberg, VIC, 3084</ethicaddress>
      <ethicapprovaldate>17/05/2009</ethicapprovaldate>
      <hrec>R09/12</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr. Maree Barnes</name>
      <address>Institute for Breathing and Sleep
Bowen Centre, Austin Health
Studley Road
Heidelberg, VIC, 3084</address>
      <phone>+61 3 9496 3688</phone>
      <fax />
      <email>maree.barnes@austin.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Danielle Wilson</name>
      <address>Institute for Breathing and Sleep
Bowen Centre, Austin Health
Studley Road
Heidelberg, VIC, 3084</address>
      <phone>+61 3 9496 3688</phone>
      <fax />
      <email>danielle.wilson@austin.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>